x

Cerca un progetto di ricerca

* (*) campo obbligatorio

27 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC =

Progetti di ricerca

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

Finanziato da un ente associato a IRDiRCNational Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
Addenbrooke's Hospital
Department of Medicine (Respiratory Medicine)

FRANCIA

AUVERGNE-RHONE-ALPES
GRENOBLE CEDEX 9

Finanziato da un ente associato a IRDiRCHHTreat: new drugs for the treatment of HHT patients
Institut de Biosciences et Biotechnologies de Grenoble (BIG) - CEA
Famille BMP dans l'angiogenèse et la lymphangiogenèse

FRANCIA

ILE-DE-FRANCE
LE PLESSIS-ROBINSON

Finanziato da un ente associato a IRDiRCNMDA receptors, Unexpected TargetS in pulmonary arterial hypertension
Centre Chirurgical Marie Lannelongue
Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique (Inserm UMR-S 999)

GERMANIA

Baden-Württemberg
HEIDELBERG

Rehabilitation program for patients with severe pulmonary arterial hypertension
Thoraxklinik-Heidelberg gGmbH
Abteilung für Pneumologie und Beatmungsmedizin

GERMANIA

Baden-Württemberg
HEIDELBERG

COMPERA / COMPERA-KIDS: Prospective registry of newly initiated therapies for Pulmonary Hypertension
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde II - Pädiatrische Kardiologie/Angeborene Herzfehler

GERMANIA

Baden-Württemberg
ULM

The TOPP-2 registry: Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
Klinik für Kinder- und Jugendmedizin des Universitätsklinikums Ulm
Sektion Pädiatrische Kardiologie

GERMANIA

Niedersachsen
HANNOVER

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

Finanziato da un ente associato a IRDiRCNIHR BioResource - Rare Disease: PAH - Pulmonary Arterial Hypertension
Addenbrooke's Hospital
Department of Medicine (Respiratory Medicine)

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

Finanziato da un ente associato a IRDiRCMechanisms underlying the development of pulmonary arterial hypertension
University of Cambridge
Department of Medicine

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCIdentification of penetrance modifier genes in rare hereditary diseases through massive sequencing
Centro de Diagnóstico Biomédico - CDB
Sección de Genética Molecular

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCStudy of the role of survivin in the pathogenesis of pulmonary arterial hypertension and its use as a potential therapeutic target
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Grupo de investigación en mecanismos fisiopatológicos de las enfermedades respiratorias

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCIdentification of penetrance modifier genes in rare hereditary diseases through massive sequencing
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Grupo de investigación en genética

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCGenetic-molecular bases of pulmonary arterial hypertension and its phenotypic expression in the Spanish population
Hospital Universitario 12 de Octubre
Unidad Multidisciplinar de Hipertensión Pulmonar

SPAGNA

Madrid
MADRID

ITALIA

CAMPANIA
NAPOLI

Finanziato da un ente associato a IRDiRCProgramma Telethon per le malattie senza diagnosi
Azienda Ospedaliera Universitaria - Seconda Università degli Studi di Napoli
Laboratorio di Genetica Medica

Progetti di ricerca multicentrici